Association Between Infliximab Concentrations and Clinical Outcomes in Pediatric Patients With Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The American Journal of Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Higher Postinduction Infliximab Concentrations Are Associated With Favorable Clinical Outcomes in Pediatric Crohn's Disease: A Post Hoc Analysis of the REACH Trial
Am. J. Gastroenterol 2023 Mar 01;118(3)485-490, AS Cheifetz, N Vande Casteele, Z Wang, MC Dubinsky, K PapamichaelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.